Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome

Published on 04/03/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 04/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 771 times

Chapter 59 Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome

Keith R. McCrae, J. Evan Sadler, Douglas B. Cines

Table 59-1 Proposed Classification Scheme for Thrombotic Microangiopathies

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here
ADVANCED UNDERSTANDING OF ETIOLOGY

Infection induced

Shiga and verocytotoxin (Shiga-like toxin)–producing bacteria
Streptococcus pneumoniae

Disorders of complement regulation

Genetic disorders of complement regulation
Acquired disorders of complement regulation, for example anti-FH antibody

ADAMTS13 abnormalities

ADAMTS13 deficiency secondary to mutations
Autoantibodies against ADAMTS13

Defective cobalamine metabolism

Quinine induced
ETIOLOGY NOT FULLY UNDERSTOOD

Related posts:

Anemia of Chronic Diseases Lysosomal Storage Diseases: Perspectives and Principles Aplastic Anemia Heme Biosynthesis and Its Disorders: Porphyrias Pain Management and Antiemetic Therapy in Hematologic Disorders Complications After Hematopoietic Stem Cell Transplantation